Photosensitivity associated with anaplastic lymphoma kinase inhibitors: A review of postmarketing cases reported to FDA and published in the literature

Photodermatol Photoimmunol Photomed. 2023 May;39(3):285-290. doi: 10.1111/phpp.12829. Epub 2022 Aug 30.
No abstract available

Keywords: anaplastic lymphoma kinase (ALK); brigatinib; ceritinib; crizotinib; photosensitivity.

Publication types

  • Review
  • Letter

MeSH terms

  • Anaplastic Lymphoma Kinase / therapeutic use
  • Antineoplastic Agents*
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / pathology
  • Protein Kinase Inhibitors / adverse effects

Substances

  • Anaplastic Lymphoma Kinase
  • Protein Kinase Inhibitors
  • Antineoplastic Agents